The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| AIDA | +50.5% | -97.85% | -53.6% | -100% |
| S&P | +12.9% | +73.65% | +11.66% | +439% |
AiDa Pharmaceuticals, Inc. engages in the development, production, and distribution of pharmaceutical products. It offers Etimicin Sulfate, an antibiotic, which treats respiratory infection, kidney and urinogenital infection, soft skin tissue infection, and trauma and operations preventive uses. The company was founded on December 18, 2002 and is headquartered in Hangzhou, China.
No news articles found for Aida Pharmaceuticals.
No data available for this period.
Currently no data to display
Currently no data to display.
Currently no data to display.
No data available for this period.
No data available for this period.
No data available for this period.
No data available for this period.
| Metric | YoY Change |
|---|
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
